France chooses companies to supply free medical cannabis for trial program
The French Agency for the Safety of Medicines and Health Products (ANSM) selected the companies that will supply France’s medical cannabis pilot […]
The French Agency for the Safety of Medicines and Health Products (ANSM) selected the companies that will supply France’s medical cannabis pilot […]
United Kingdom-based GW Pharmaceuticals expects to report annual sales of roughly $526 million for the year ended Dec. 31, 2020, the company […]
Bermuda is taking its first steps to formally lay the legal groundwork for a regulated adult-use and medical cannabis industry, potentially setting […]
The United Kingdom will decline to approve a 6-month-old bill to open commercial opportunities involving medical cannabis in the British Virgin Islands […]
The United Kingdom’s representative in the British Virgin Islands (BVI) has so far declined to sign off on a new law to […]
There is an ineffable logic to the pace of reform these days. Nowhere is that clearer in both the success of voter […]
The growing number of medical cannabis brands and products available to patients in Germany indicates that companies wanting to enter and succeed […]
The cannabis marketplace is an ever changing one. The opportunities being generated in the UK space are immense. Yet despite the countless […]
Dr. Philipp Rösler, the former federal Minister of Economics and Technology and Vice Chancellor of Germany from 2011-2013 has just joined the […]
United Kingdom-based GW Pharmaceuticals posted marginal revenue growth in the second quarter over the previous quarter, citing challenges stemming from the COVID-19 […]